Skip to main content
Retour
SHPPF logo

Redcare Pharmacy N.V.

Qualité des données : 100%
Survendu
SHPPF
OTC Healthcare Medical - Pharmaceuticals
45,18 €
0,00 € (0,00%)
Cap. Boursière : 919,02M
Également cotée sous SAEYY OTC
Fourchette du Jour
45,18 € 62,99 €
Fourchette 52 Semaines
45,18 € 148,22 €
Volume
400
Moyenne 50J / 200J
66,04 € / 102,10 €
Clôture Précédente
45,18 €

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Healthcare (626 pairs)

Métrique Action Médiane du Secteur
P/E -24,4 0,4
P/B 2,0 2,9
ROE % -8,0 3,7
Net Margin % -1,3 3,8
Rev Growth 5Y % 29,0 10,0
D/E 0,9 0,2

Points Clés

Revenue grew 29,04% annually over 5 years — strong growth
Negative free cash flow of -56,28M
Revenue growth is decelerating — 1Y growth trails 5Y average by 5,03%
Capital efficient — spends only 2,70% of revenue on capex

Croissance

Revenue Growth (5Y)
29,04%
Revenue (1Y)24,01%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-7,99%
ROIC-2,04%
Net Margin-1,28%
Op. Margin-0,81%

Sécurité

Debt / Equity
0,91
Current Ratio1,55
Interest Coverage-1,17

Valorisation

P/E Ratio
-24,39
P/B Ratio2,00
EV/EBITDAN/A
Dividend Yield0,00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 24,01% Revenue Growth (3Y) 27,84%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 29,04% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 2,94B Net Income (TTM) -37,69M
ROE -7,99% ROA -3,02%
Gross Margin 20,19% Operating Margin -0,81%
Net Margin -1,28% Free Cash Flow (TTM) -56,28M
ROIC -2,04% FCF Growth (3Y) N/A
Safety
Debt / Equity 0,91 Current Ratio 1,55
Interest Coverage -1,17 Dividend Yield 0,00%
Valuation
P/E Ratio -24,39 P/B Ratio 2,00
P/S Ratio 0,31 PEG Ratio 1,97
EV/EBITDA N/A Dividend Yield 0,00%
Market Cap 919,02M Enterprise Value 1,24B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 2,94B 2,37B 1,80B 1,20B 1,06B
Net Income -37,69M -45,46M -12,04M -77,65M -74,19M
EPS (Diluted) -1,87 -2,26 -0,63 -4,32 -4,15
Gross Profit 593,48M 545,78M 440,38M 331,79M 266,53M
Operating Income -23,79M -38,99M -17,30M -69,17M -65,70M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 1,25B 1,00B 1,02B 729,47M 783,08M
Total Liabilities 767,01M 493,32M 469,56M 374,84M 367,66M
Shareholders' Equity 459,03M 483,98M 522,19M 354,63M 415,41M
Total Debt 415,44M 247,38M 244,84M 255,19M 236,43M
Cash & Equivalents 92,37M 96,61M 83,78M 66,44M 247,08M
Current Assets 619,17M 500,02M 499,52M 343,92M 432,76M
Current Liabilities 399,85M 249,73M 223,72M 119,31M 124,09M

Scores de Stratégies

This stock passed the criteria for 2 strategies

Score = fit strength (0–100)
Rank = position among all matches
#105 of 616
66
Custom Full Throttle
#96 of 146
35

Activité Récente

Entré Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026
Entré Full Throttle
Mar 24, 2026